Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...
ADVERTISEMENT
Tag: Astellas Pharma
ADVERTISEMENT
Popular Last 24h
-
RFE/RL: Letter from Congress Urges U.S. Secretary of State Nominee Marco Rubio to Sanction Ivanishvili’s “Enablers”
-
What time is SpaceX’s Starship Flight 7 launch test on Jan. 13?
-
Scope Ratings Revised the Republic of Georgia’s Credit Ratings and Outlooks to Negative
-
Governor Newsom signs executive order to help Los Angeles rebuild faster and stronger
-
Most international migrants don’t move very far from their home countries
-
Real Estate in Focus: 2025 Trends to Watch
-
Simone Biles ‘Never Imagined’ Winning Multiple Medals When She Started Gymnastics
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
